Listen for Patients on a "Flozin" Talking About Sudden Illness
See updated FDA information (December 2015) concerning SGLT2 inhibitors (Flozins) and ketoacidosis/urinary tract infections.You'll see new warnings about whether "flozins" (Invokana and Forxiga) increase the risk of elevated "ketones" in the blood.
Having high ketones in the blood can lead to coma and death.
Ketoacidosis is most commonly seen in patients with VERY high blood sugar. In these cases, there isn't enough insulin to move all the sugar into the cells to fuel the body's needs...so the body breaks down fat instead, resulting in elevated ketones in the blood.